Effect of Cricoid Pressure Compared With a Sham Procedure in the Rapid Sequence Induction of Anesthesia: The IRIS Randomized Clinical Trial

Aurélie Birenbaum, David Hajage, Sabine Roche, Alexandre Ntouba, Mathilde Eurin, Philippe Cuvillon, Aurélien Rohn, Vincent Compere, Dan Benhamou, Matthieu Biais, Remi Menut, Sabiha Benachi, François Lenfant, Bruno Riou, IRIS Investigators Group, Aurélie Birenbaum, David Hajage, Sabine Roche, Alexandre Ntouba, Mathilde Eurin, Philippe Cuvillon, Aurélien Rohn, Vincent Compere, Dan Benhamou, Matthieu Biais, Remi Menut, Sabiha Benachi, François Lenfant, Bruno Riou, IRIS Investigators Group

Abstract

Importance: The use of cricoid pressure (Sellick maneuver) during rapid sequence induction (RSI) of anesthesia remains controversial in the absence of a large randomized trial.

Objective: To test the hypothesis that the incidence of pulmonary aspiration is not increased when cricoid pressure is not performed.

Design, setting, and participants: Randomized, double-blind, noninferiority trial conducted in 10 academic centers. Patients undergoing anesthesia with RSI were enrolled from February 2014 until February 2017 and followed up for 28 days or until hospital discharge (last follow-up, February 8, 2017).

Interventions: Patients were assigned to a cricoid pressure (Sellick group) or a sham procedure group.

Main outcomes and measures: Primary end point was the incidence of pulmonary aspiration (at the glottis level during laryngoscopy or by tracheal aspiration after intubation). It was hypothesized that the sham procedure would not be inferior to the cricoid pressure. The secondary end points were related to pulmonary aspiration, difficult tracheal intubation, and traumatic complications owing to the tracheal intubation or cricoid pressure.

Results: Of 3472 patients randomized, mean (SD) age was 51 (19) years and 1777 (51%) were men. The primary end point, pulmonary aspiration, occurred in 10 patients (0.6%) in the Sellick group and in 9 patients (0.5%) in the sham group. The upper limit of the 1-sided 95% CI of relative risk was 2.00, exceeding 1.50, failing to demonstrate noninferiority (P = .14). The risk difference was -0.06% (2-sided 95% CI, -0.57 to 0.42) in the intent-to-treat population and -0.06% (2-sided 95% CI, -0.56 to 0.43) in the per protocol population. Secondary end points were not significantly different among the 2 groups (pneumonia, length of stay, and mortality), although the comparison of the Cormack and Lehane grade (Grades 3 and 4, 10% vs 5%; P <.001) and the longer intubation time (Intubation time >30 seconds, 47% vs 40%; P <.001) suggest an increased difficulty of tracheal intubation in the Sellick group.

Conclusions and relevance: This large randomized clinical trial performed in patients undergoing anesthesia with RSI failed to demonstrate the noninferiority of the sham procedure in preventing pulmonary aspiration. Further studies are required in pregnant women and outside the operating room.

Trial registration: ClinicalTrials.gov Identifier: NCT02080754.

Conflict of interest statement

Conflict of Interest Disclosures: Dr Biais reported personal fees from Maquet Critical Care and from Edwards Lifesciences outside the submitted work. No other disclosures were reported.

Figures

Figure 1.. Flow of Participants Through the…
Figure 1.. Flow of Participants Through the Study
ITT indicates intention to treat; PP, per protocol. aIncluding 1 patient with allergy to succinylcholine. bThis refers to the same patient.
Figure 2.. Comparison of the Incidence of…
Figure 2.. Comparison of the Incidence of Pulmonary Aspiration (Primary End Point) Between the Sellick Group and the Sham Group
The points represent the estimates of relative risk (sham group/Sellick group), and the horizontal bars represent the associated 2-sided 90% CI. The upper limits are identical to those of the 1-sided 95% CI used in this study for establishing noninferiority. Clinical noninferiority of the sham procedure would be accepted if the upper limit of these intervals fell below the predefined noninferiority margin represented in red dotted line.

Source: PubMed

3
구독하다